MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 49571-49580 Newer>
The Motley Fool
June 27, 2011
Andrew Tonner
Does Texas Instruments Deserve a Spot in Your Portfolio? In its sector, Texas Instruments could make for a potential stock to own upon further research. mark for My Articles 191 similar articles
The Motley Fool
June 27, 2011
Shubh Datta
1 Surprising Buy in a Long-Overlooked Sector Things are looking up for AutoZone; the stock is reasonably priced and should provide some good returns. mark for My Articles 121 similar articles
The Motley Fool
June 27, 2011
Travis Hoium
3 Tasty Stocks That Are Good for You and Your Wallet These stocks will fuel you and your portfolio: Chipotle... Panera Bread... Whole Foods... mark for My Articles 316 similar articles
The Motley Fool
June 27, 2011
Tim Beyers
Does Google Need to Be Broken Up? The FTC takes a closer look at the Big G's business practices. mark for My Articles 206 similar articles
The Motley Fool
June 27, 2011
Shubh Datta
All Is Not Yet Right at Rite Aid Drug retailer Rite Aid posts losses in its first fiscal quarter and sees further losses ahead. mark for My Articles 209 similar articles
The Motley Fool
June 27, 2011
Adam J. Crawford
Natural Gas Finds Its Niche Meet the newest fleet fuel. mark for My Articles 648 similar articles
The Motley Fool
June 27, 2011
Neha Chamaria
1 Financial Stock Definitely Worth Discovering Discover Financial's quarterly numbers beat estimates, look positive. mark for My Articles 374 similar articles
The Motley Fool
June 27, 2011
Eric Bleeker
Starbucks' Growth Strategy: Go Abroad We'll examine where Starbucks' sales and earnings come from, and how its sales abroad have changed over time. mark for My Articles 615 similar articles
The Motley Fool
June 27, 2011
Brian Orelli
Double Ouch! 2 Monster Drops in 2 Trading Days Perhaps investors in Pain Therapeutics and DURECT would have rather been kept in the dark about these FDA rejections. mark for My Articles 86 similar articles
The Motley Fool
June 27, 2011
Eric Bleeker
What's Driving IBM's Profits Forward? Where's IBM generating its sales? mark for My Articles 1426 similar articles
<Older 49571-49580 Newer>    Return to current articles.